European Union - English - EMA (European Medicines Agency)

sanofi b.v. - thyrotropin alfa - thyroid neoplasms - anterior pituitary lobe hormones and analogues, pituitary and hypothalamic hormones and analogues - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst).low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels.thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1.1 gbq) to 100 mci (3.7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.4).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

genzyme therapeutics ltd - thyrotropin alfa - powder for solution for injection - 900microgram

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - thyrotropin alfa - injection, powder, for solution - 1.1 mg - thyrotropin alfa 1.1 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

genzyme europe b.v., netherlands - thyrotropin alfa - powder for solution for injection - 0.9 mg/ml

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة ألفه للأدوية - ulfa pharma co. - thyrotropin alfa 0.9 mg - 0.9 mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة ألفه للأدوية - ulfa pharma co. - thyrotropin alfa 0.9 mg - 0.9 mg

Canada - English - Health Canada

sanofi genzyme, a division of sanofi-aventis canada inc - thyrotropin alfa - powder for solution - 0.9mg - thyrotropin alfa 0.9mg - thyroid function

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - thyrotropin alfa, quantity: 1.1 mg - injection, powder for - excipient ingredients: nitrogen; dibasic sodium phosphate heptahydrate; monobasic sodium phosphate monohydrate; sodium chloride; mannitol - thyrogen is indicated for use with serum thyroglobulin (tg) testing, with or without radioactive iodine imaging and undertaken for the detection of thyroid remnants and well-differentiated thyroid cancer in post-thyroidectomy patients maintained on hormone suppression therapy. therapeutic use in post-thyroidectomy patients maintained on hormone suppression therapy in the ablation of thyroid remnant tissue in combination with radioactive iodine.